Management of nausea and vomiting in patients with advanced cancer at the end of life
- PMID: 29094534
- DOI: 10.7748/ns.2017.e10993
Management of nausea and vomiting in patients with advanced cancer at the end of life
Abstract
The prevalence of nausea and vomiting in patients with advanced cancer varies, but it generally increases towards the end of life. Nausea and vomiting can be distressing and debilitating for patients, and can affect quality of life significantly. This article discusses the assessment of nausea and vomiting, current understanding of the emetic pathways, and pharmacological management of nausea and vomiting in patients with advanced cancer at the end of life.
Keywords: advanced cancer; anti-emetics; assessment; end of life; nausea; pharmacological management; quality of life; symptom management; vomiting.
©2012 RCN Publishing Company Ltd. All rights reserved. Not to be copied, transmitted or recorded in any way, in whole or part, without prior permission of the publishers.
Conflict of interest statement
None declared
LinkOut - more resources
Other Literature Sources